Clinical study offer

🫃 Paid Ulcerative Colitis Clinical Trials

Browse recruiting ulcerative colitis clinical trials across the United States. Find eligibility information, locations and research opportunities near you.

Loading...
Active Studies
Ulcerative Colitis
Condition

Active Clinical Trials for Ulcerative Colitis

Showing live studies from ClinicalTrials.gov. Data refreshes daily.

Loading studies...

Disclaimer: This content is for educational purposes and is not medical advice. Always consult a qualified healthcare provider for medical guidance.

About Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory bowel disease causing inflammation and ulcers in the colon and rectum. Clinical trials investigate biologic therapies, small molecule inhibitors, and microbiome-based treatments to induce and maintain remission.

Common Symptoms

Diarrhea with blood or pus, abdominal pain, rectal pain, urgency, fecal incontinence, fatigue, weight loss, fever, anemia

Risk Factors

Family history, age (usually 15-30), ethnic background (higher in Caucasians and Ashkenazi Jews), certain environmental factors, immune system abnormalities

Treatment Overview

Treatment includes aminosalicylates, corticosteroids, immunomodulators, biologic therapies (anti-TNF, anti-integrin), JAK inhibitors, and colectomy for severe cases. Clinical trials explore S1P receptor modulators, IL-23 inhibitors, and fecal microbiota transplantation.

Why Participate?

Ulcerative colitis clinical trials advance treatment options for achieving steroid-free remission and preventing disease complications.

Related Conditions

States with Ulcerative Colitis Clinical Trials

Cities with Ulcerative Colitis Clinical Trials

Frequently Asked Questions About Ulcerative Colitis Clinical Trials

Ulcerative colitis clinical trials test new medications and therapies to reduce colon inflammation and maintain long-term remission. Studies evaluate both oral and injectable treatments with different mechanisms of action.
Eligibility depends on disease extent and severity, prior treatment response, and whether complications are present. Studies often require endoscopic confirmation of active disease.
Compensation varies. Participants typically receive $50-$200 per visit with colonoscopies and lab work provided at no cost.
Yes, participants receive regular monitoring including blood tests and endoscopic evaluations as needed. Independent safety committees oversee all trials.